Heart Failure study: Virtual HF Care vs Routine HF Care
Official title VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization
ClinicalTrials.gov ID: NCT05724433
What this study is testing
- What it's testing
- The study wants to see if virtual care can help patients recover better after being hospitalized for heart failure.
- Who it's for
- It is looking for people who have been in the hospital for heart failure.
- What's involved
- Participants will have clinic visits for 90 days and then be followed up for 180 days to check medication use and health status.
- Time commitment
- The study lasts 90 days of visits, with outcomes measured at 180 days.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Are being discharged after hospitalization or urgent visit for HF as
- a primary diagnosis or
- significant complication (prolonging length of stay) of another diagnosis OR Have been referred for an initial consult at a cardiology clinic within...
- Have left ventricular ejection fraction (LVEF) \< 50% within the preceding 3 months.
- Have NT-proBNP of \> 900 pg/ml during hospital admission or within 7 days after discharge from the ED
You likely can't join if
- Died or left hospital before medically advised hospital discharge
- Unable to self-assess or communicate symptoms (e.g. clinically evident dementia)
- Unable to engage with digital health technology or follow up
- Severe valve disease
- Recipient of or on waiting list for LVAD or cardiac transplant
- Complex congenital heart disease, hypertrophic obstructive cardiomyopathy, or amyloid cardiomyopathy
See the full eligibility criteria
- Are being discharged after hospitalization or urgent visit for HF as
- a primary diagnosis or
- significant complication (prolonging length of stay) of another diagnosis OR Have been referred for an initial consult at a cardiology clinic within 1 week of hospitalization or urgent visit for HF as a primary or...
- Have left ventricular ejection fraction (LVEF) \< 50% within the preceding 3 months.
- Have NT-proBNP of \> 900 pg/ml during hospital admission or within 7 days after discharge from the ED
- Have a mailing address for patient or caregiver
- Provide verbal consent
- Died or left hospital before medically advised hospital discharge
- Unable to self-assess or communicate symptoms (e.g. clinically evident dementia)
- Unable to engage with digital health technology or follow up
- Severe valve disease
- Recipient of or on waiting list for LVAD or cardiac transplant
- Complex congenital heart disease, hypertrophic obstructive cardiomyopathy, or amyloid cardiomyopathy
- Severe lung disease with symptoms on minimal exertion, forced expiratory volume during 1 second (FEV1) \ 60 mm Hg, or on home oxygen
- Severe kidney disease (persistent eGFR \< 30 mL/min/1.73m2)
- Active malignancy
- Receiving palliative care or expected life expectancy \< 6 months
The study team makes the final eligibility decision.
Where it is enrolling
- Hamilton, Onatrio, Canada
- Hamilton, Ontario, Canada
- Toronto, Ontario, Canada
- Monastir, Tunisia
- Sfax, Tunisia
- Sousse, Tunisia
- Tunis, Tunisia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hamilton, Onatrio, Canada; Hamilton, Ontario, Canada; Toronto, Ontario, Canada; Monastir, Tunisia; Sfax, Tunisia; Sousse, Tunisia and 1 more location. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.